Keros Therapeutics
KROS
KROS
105 hedge funds and large institutions have $893M invested in Keros Therapeutics in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 24 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
0.6% less ownership
Funds ownership: 69.05% → 68.44% (-0.6%)
5% less capital invested
Capital invested by funds: $944M → $893M (-$51.1M)
Holders
105
Holding in Top 10
5
Calls
$5.68M
Puts
$5K
Top Buyers
| 1 | +$9.84M | |
| 2 | +$9.77M | |
| 3 | +$5.77M | |
| 4 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
+$5.66M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$4.37M |
Top Sellers
| 1 | -$27M | |
| 2 | -$6.52M | |
| 3 | -$3.69M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$2.72M |
| 5 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$1.33M |